BLENREP
Biological
GlaxoSmithKline, LLC.
Total Payments
$12.9M
Transactions
11,705
Doctors
4,346
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $2,229 | 6 | 6 |
| 2023 | $139,176 | 53 | 19 |
| 2022 | $6.8M | 5,541 | 2,835 |
| 2021 | $5.4M | 4,872 | 2,349 |
| 2020 | $537,945 | 1,233 | 765 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $9.0M | 138 | 70.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.6M | 903 | 20.5% |
| Consulting Fee | $683,948 | 393 | 5.3% |
| Food and Beverage | $306,261 | 9,811 | 2.4% |
| Travel and Lodging | $219,250 | 451 | 1.7% |
| Space rental or facility fees (teaching hospital only) | $10,500 | 4 | 0.1% |
| Education | $61.25 | 5 | 0.0% |
Payments by Type
Research
$9.0M
138 transactions
General
$3.9M
11,567 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 0000000000000000000000000000000000000000000000000000000000000000213312 | GlaxoSmithKline, LLC. | $3.2M | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000213321 | GlaxoSmithKline, LLC. | $1.0M | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000213316 | GlaxoSmithKline, LLC. | $1.0M | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214610 | GlaxoSmithKline, LLC. | $874,981 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214647 | GlaxoSmithKline, LLC. | $807,626 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214611 | GlaxoSmithKline, LLC. | $532,418 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214644 | GlaxoSmithKline, LLC. | $504,795 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000213313 | GlaxoSmithKline, LLC. | $348,753 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214649 | GlaxoSmithKline, LLC. | $191,599 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214687 | GlaxoSmithKline, LLC. | $132,397 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000215122 | GlaxoSmithKline, LLC. | $132,397 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214608 | GlaxoSmithKline, LLC. | $52,959 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214643 | GlaxoSmithKline, LLC. | $52,959 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214605 | GlaxoSmithKline, LLC. | $51,667 | 0 |
| 213321 | GlaxoSmithKline, LLC. | $20,657 | 0 |
| 213313 | GlaxoSmithKline, LLC. | $15,493 | 0 |
| 213316 | GlaxoSmithKline, LLC. | $15,493 | 0 |
| 214611 | GlaxoSmithKline, LLC. | $15,148 | 0 |
| 213312 | GlaxoSmithKline, LLC. | $12,738 | 0 |
| 214647 | GlaxoSmithKline, LLC. | $11,706 | 0 |
Top Doctors Receiving Payments for BLENREP — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , APRN | Registered Nurse | Bridgeport, CT | $21,159 | 18 |
| , MD | Medical Oncology | Memphis, TN | $20,592 | 11 |
| , M.D | Hematology & Oncology | Pittsburgh, PA | $20,480 | 10 |
| , M.D | Medical Oncology | Washington, DC | $19,261 | 8 |
| , MD | Hematology & Oncology | Gilbert, AZ | $18,753 | 7 |
| , M.D | Internal Medicine | Spartanburg, SC | $18,717 | 9 |
| , M.D | Specialist | Beverly Hills, CA | $18,693 | 13 |
| , M.D | Specialist | Columbia, MD | $18,351 | 8 |
| , APRN | Family | Salt Lake City, UT | $17,541 | 24 |
| , CNS | Oncology | Saint Louis, MO | $16,390 | 21 |
| , M.D | Internal Medicine | Casper, WY | $16,263 | 17 |
| , M.D., PH.D | Ophthalmology | Palm Beach Gardens, FL | $16,197 | 8 |
| , MD, PHD | Hematology & Oncology | Tampa, FL | $15,724 | 8 |
| , MD | Ophthalmology | Blue Ash, OH | $14,175 | 7 |
| , M.D | Medical Oncology | Houston, TX | $13,697 | 8 |
| , OD | Optometrist | Cleveland, OH | $13,125 | 16 |
| , NP | Family | Tucson, AZ | $13,053 | 17 |
| , MD | Hematology | Washington, DC | $11,650 | 6 |
| , MD | Internal Medicine | Milwaukee, WI | $11,550 | 4 |
| , M.D | Hematology | Salt Lake City, UT | $11,288 | 7 |
| , PA-C | Medical | Kalamazoo, MI | $11,275 | 18 |
| , MD | Ophthalmology | Baltimore, MD | $10,888 | 4 |
| , NP | Nurse Practitioner | Stanford, CA | $10,562 | 17 |
| , MD | Hematology | Flowood, MS | $10,124 | 9 |
| , MD | Internal Medicine | Seattle, WA | $9,200 | 4 |
Ad
Manufacturing Companies
- GlaxoSmithKline, LLC. $12.9M
Product Information
- Type Biological
- Total Payments $12.9M
- Total Doctors 4,346
- Transactions 11,705
About BLENREP
BLENREP is a biological associated with $12.9M in payments to 4,346 healthcare providers, recorded across 11,705 transactions in the CMS Open Payments database. The primary manufacturer is GlaxoSmithKline, LLC..
Payment data is available from 2020 to 2024. In 2024, $2,229 was paid across 6 transactions to 6 doctors.
The most common payment nature for BLENREP is "Unspecified" ($9.0M, 70.1% of total).
BLENREP is associated with 20 research studies, including "0000000000000000000000000000000000000000000000000000000000000000213312" ($3.2M).